Unlike DNMT3A whose mutation is often observed in AML patients and is regarded as a preleukaemic mutation promoting acute myeloid leukaemogenesis [117], DNMT1 mutation is rarely observed during the progression of AML. This evidence concerns the gene DNMT3A and acute myeloid leukemia.